New cancer vaccine is 100 percent successful in mouse model

Scientists have developed a new vaccine that — in conjunction with existing therapies — can not only treat...

October 15, 2018

Scientists have developed a new vaccine that — in conjunction with existing therapies — can not only treat aggressive melanoma, but also prevent its recurrence.

Researchers from the Scripps Research Institute in San Diego, CA, recently worked with experts from other institutions to develop a vaccine that would be effective against melanoma (a type of skin cancer) when administered in conjunction with other therapies.

Read more here

By Maria Cohut – Medical News Today

Join us in the fight against melanoma

With your help, over the past 35+ years, we’ve been working to defeat melanoma—and we know the work we’re doing is making a real difference. But there’s still much more to do.

In the Hunter New England Local Health District, melanoma is now the second most diagnosed cancer (Cancer Institute NSW, February 2024), underscoring the urgent need for continued awareness, early detection, and prevention.

Nationally, melanoma remains the most common cancer among Australians aged 20 to 39. Your donation and ongoing support allow us to continue this life-saving work—funding education programs, supporting patients, and advancing research to reduce the impact of melanoma in our community.